Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced or Metastatic Solid Tumors × surufatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 1 Neuroendocrine Tumors 1 Neoplasms 1 Advanced or Metastatic Solid Tumors 1

Interventions

pembrolizumab 3 envafolimab 3 Nivolumab 2 trifluridine tipiracil drug combination 1 tebentafusp 1 surufatinib 1 sintilimab 1 linifanib 1 Injections 1 Drug Therapy 1 Doxorubicin 1 Combined Modality Therapy 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04427774 2021-07-20

A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Terminated

Other solid neoplasm

Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡